|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
3
|
Tsilidis KK, Allen NE, Key TJ, Dossus L,
Kaaks R, Bakken K, Lund E, Fournier A, Dahm CC, Overvad K, Hansen
L, Tjønneland A, Rinaldi S, Romieu I, Boutron-Ruault MC,
Clavel-Chapelon F, Lukanova A, Boeing H, Schütze M, Benetou V,
Palli D, Berrino F, Galasso R, Tumino R, Sacerdote C,
Bueno-de-Mesquita HB, van Duijnhoven FJ, Braem MG, Onland-Moret NC,
Gram IT, Rodríguez L, Duell EJ, Sánchez MJ, Huerta JM, Ardanaz E,
Amiano P, Khaw KT, Wareham N and Riboli E: Menopausal hormone
therapy and risk of ovarian cancer in the European prospective
investigation into cancer and nutrition. Cancer Causes Control.
22:1075–1084. 2011. View Article : Google Scholar
|
|
4
|
Park SH, Cheung LW, Wong AS and Leung PC:
Estrogen regulates snail and slug in the down-regulation of
E-cadherin and induces metastatic potential of ovarian cancer cells
through estrogen receptor alpha. Mol Endocrinol. 22:2085–2098.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hua K, Din J, Cao Q, Feng W, Zhang Y, Yao
L, Huang Y, Zhao Y and Feng Y: Estrogen and progestin regulate
HIF-1α expression in ovarian cancer cell lines via the activation
of Akt signaling transduction pathway. Oncol Rep. 21:893–898.
2009.
|
|
6
|
Hua K, Feng W, Cao Q, Zhou X, Lu X and
Feng Y: Estrogen and progestin regulate metastasis through the
PI3K/AKT pathway in human ovarian cancer. Int J Oncol. 33:959–967.
2008.PubMed/NCBI
|
|
7
|
Ding JX, Feng YJ, Yao LQ, Yu M, Jin HY and
Yin LH: The reinforcement of invasion in epithelial ovarian cancer
cells by 17β-estradiol is associated with upregulation of Snail.
Gynecol Oncol. 103:623–630. 2006.PubMed/NCBI
|
|
8
|
Spillman MA, Manning NG, Dye WW, Sartorius
CA, Post MD, Harrell JC, Jacobsen BM and Horwitz KB:
Tissue-specific pathways for estrogen regulation of ovarian cancer
growth and metastasis. Cancer Res. 70:8927–8936. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Laviolette LA, Garson K, Macdonald EA,
Senterman MK, Courville K, Crane CA and Vanderhyden BC:
17β-estradiol accelerates tumor onset and decreases survival in a
transgenic mouse model of ovarian cancer. Endocrinology.
151:929–938. 2010.
|
|
10
|
Twal WO, Czirok A, Hegedus B, Knaak C,
Chintalapudi MR, Okagawa H, Sugi Y and Argraves WS: Fibulin-1
suppression of fibronectin regulated cell adhesion and motility. J
Cell Sci. 114:4587–4598. 2001.PubMed/NCBI
|
|
11
|
Rochefort H, Chalbos D, Cunat S, Lucas A,
Platet N and Garcia M: Estrogen regulated proteases and
antiproteases in ovarian and breast cancer cells. J Steroid Biochem
Mol Biol. 76:119–124. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P,
Kong B, Li R, West RB, van de Vijver MJ, Sukumar S and Chang HY:
Long non-coding RNA HOTAIR reprograms chromatin state to promote
cancer metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Matouk IJ, DeGroot N, Mezan S, Ayesh S,
Abu-lail R, Hochberg A and Galun E: The H19 non-coding RNA is
essential for human tumor growth. PLoS One. 2:e8452007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Du Y, Kong G, You X, Zhang S, Zhang T, Gao
Y, Ye L and Zhang X: Elevation of highly up-regulated in liver
cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell
proliferation via down-regulating p18. J Biol Chem.
287:26302–26311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
Attardi LD, Regev A, Lander ES, Jacks T and Rinn JL: A large
intergenic noncoding RNA induced by p53 mediates global gene
repression in the p53 response. Cell. 142:409–419. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: a tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Silva JM, Boczek NJ, Berres MW, Ma X and
Smith DI: LSINCT5 is over expressed in breast and ovarian cancer
and affects cellular proliferation. RNA Biol. 8:496–505. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rangel LB, Sherman-Baust CA, Wernyj RP,
Schwartz DR, Cho KR and Morin PJ: Characterization of novel human
ovarian cancer-specific transcripts (HOSTs) identified by serial
analysis of gene expression. Oncogene. 22:7225–7232. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu W, Seok J, Mindrinos MN, Schweitzer AC,
Jiang H, Wilhelmy J, Clark TA, Kapur K, Xing Y, Faham M, Storey JD,
Moldawer LL, Maier RV, Tompkins RG, Wong WH, Davis RW and Xiao W:
Human transcriptome array for high-throughput clinical studies.
Proc Natl Acad Sci USA. 108:3707–3712. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia H, Osak M, Bogu GK, Stanton LW,
Johnson R and Lipovich L: Genome-wide computational identification
and manual annotation of human long noncoding RNA genes. RNA.
16:1478–1487. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tafer H and Hofacker IL: RNAplex: a fast
tool for RNA-RNA interaction search. Bioinformatics. 24:2657–2663.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for Annotation,
Visualization, and Integrated Discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang C, Han L, Zhang A, Yang W, Zhou X,
Pu P, Du Y, Zeng H and Kang C: Global changes of mRNA expression
reveals an increased activity of the interferon-induced signal
transducer and activator of transcription (STAT) pathway by
repression of miR-221/222 in glioblastoma U251 cells. Int J Oncol.
36:1503–1512. 2010.PubMed/NCBI
|
|
27
|
Yang XY, Xi MR, Yang KX and Yu H:
Prognostic value of estrogen receptor and progesterone receptor
status in young Chinese ovarian carcinoma patients. Gynecol Oncol.
113:99–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pujol P, Rey JM, Nirde P, Roger P,
Gastaldi M, Laffargue F, Rochefort H and Maudelonde T: Differential
expression of estrogen receptor-α and -β messenger RNAs as a
potential marker of ovarian carcinogenesis. Cancer Res.
58:5367–5373. 1998.
|
|
29
|
Darb-Esfahani S, Wirtz RM, Sinn BV,
Budczies J, Noske A, Weichert W, Faggad A, Scharff S, Sehouli J,
Oskay-Ozcelik G, Zamagni C, De Iaco P, Martoni A, Dietel M and
Denkert C: Estrogen receptor 1 mRNA is a prognostic factor in
ovarian carcinoma: determination by kinetic PCR in formalin-fixed
paraffin-embedded tissue. Endocr Relat Cancer. 16:1229–1239. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan SX, Yang F, Yang Y, Tao QF, Zhang J,
Huang G, Yang Y, Wang RY, Yang S, Huo XS, Zhang L, Wang F, Sun SH
and Zhou WP: Long noncoding RNA associated with microvascular
invasion in hepatocellular carcinoma promotes angiogenesis and
serves as a predictor for hepatocellular carcinoma patients’ poor
recurrence-free survival after hepatectomy. Hepatology.
56:2231–2241. 2012.PubMed/NCBI
|
|
31
|
Bussemakers MJ, van Bokhoven A, Verhaegh
GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N and Isaacs
WB: DD3: a new prostate-specific gene, highly overexpressed in
prostate cancer. Cancer Res. 9:5975–5979. 1999.PubMed/NCBI
|
|
32
|
Srikantan V, Zou Z, Petrovics G, Xu L,
Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino
K, Buzard GS, Mostofi FK, McLeod DG, Moul JW and Srivastava S:
PCGEM1, a prostate-specific gene, is overexpressed in
prostate cancer. Proc Natl Acad Sci USA. 97:12216–12221. 2000.
View Article : Google Scholar
|
